Increasing Awareness of Preventive Healthcare Drives Genetic Testing Services Market
May 4
<p>The global <strong><a href="mailto:https://www.transparencymarketresearch.com/genetic-testing-services-market.html">genetic testing services market</a></strong> was valued at USD 15.0 billion in 2022 and is projected to exceed USD 31.5 billion by the end of 2031, growing at a CAGR of 8.4% from 2023 to 2031. The market is driven by increasing demand for personalized medicine, rising awareness of early disease detection, and advancements in genomic technologies across healthcare and research sectors.</p><p>Increase in prevalence of genetic disorders and rise in awareness about personalized medicine is driving the genetic testing services market size. Advancements in technology, such as next-generation sequencing and gene editing techniques, have improved the accuracy, efficiency, and affordability of genetic testing, further fueling market expansion.</p><p><strong>Dive Deeper into Data: Get Your In-Depth Sample Now! <a href="https://www.transparencymarketresearch.com/sample/sample.php?flag=S&amp;rep_id=10235">https://www.transparencymarketresearch.com/sample/sample.php?flag=S&amp;rep_id=10235</a> </strong></p><p>Increase in adoption of direct-to-consumer gene testing kits has made genetic testing more accessible to individuals. These kits allow consumers to obtain genetic information from the comfort of their homes, enabling personalized health management and ancestry exploration, thereby boosting the genetic testing services industry.</p><p><strong>Key Findings of the Market Report</strong></p><ul><li><strong>Diagnostic Testing</strong> and <strong>Carrier Screening</strong> are the largest segments, with carrier testing accounting for <strong>27.5%</strong> of the market in 2026.</li><li><strong>Oncology</strong> is the fastest-growing application, with a projected <strong>17.1% CAGR</strong>, as liquid biopsies become a primary tool for cancer monitoring.</li><li><strong>Next-Generation Sequencing (NGS)</strong> captured <strong>46.13%</strong> of technology revenue in 2025 and remains the gold standard for comprehensive genomic profiling in 2026.</li><li><strong>Hospitals & Clinics</strong> remain the primary end-users, holding a <strong>42.41% share</strong>, though specialized diagnostic laboratories are seeing rapid expansion.</li></ul><p><strong>Global Market: Growth Drivers</strong></p><ul><li><strong>Prevalence of Rare and Chronic Diseases:</strong> With 72–80% of rare diseases linked to genetic mutations, early testing is increasingly mandated by global health bodies.</li><li><strong>Personalized Medicine (Pharmacogenomics):</strong> Increasing use of genetic data to tailor drug dosages and avoid adverse reactions (ADRs).</li><li><strong>AI and Cloud Integration:</strong> Shift from high-CAPEX local servers to cloud-based AI interpretation platforms billed as recurring subscriptions.</li><li><strong>Mainstream Insurance Coverage:</strong> Expanding reimbursement policies in developed markets for prenatal screening and hereditary cancer panels.</li></ul><p><strong>Global Market: Key Players</strong></p><p>The competitive landscape is characterized by a mix of specialized genomic pioneers and massive diagnostic conglomerates.</p><ul><li>Illumina, Inc.</li><li>Thermo Fisher Scientific Inc.</li><li>Quest Diagnostics Inc.</li><li>Laboratory Corp of America Holdings (LabCorp)</li><li>F. Hoffmann-La Roche Ltd</li><li>Eurofins Scientific SE</li><li>Exact Sciences Corp</li><li>Myriad Genetics, Inc.</li><li>23andMe Holding Co. (DTC Leader)</li><li>GeneDx</li><li>NeoGenomics Laboratories</li></ul><p><strong>Global Market: Segmentation</strong></p><p><strong>By Test Type</strong></p><ul><li>Carrier Testing (2026 Leader)</li><li>Diagnostic Testing</li><li>Prenatal & Newborn Screening</li><li>Predictive & Presymptomatic Testing</li><li>Pharmacogenomic Testing</li></ul><p><strong>By Technology</strong></p><ul><li>Next-Generation Sequencing (NGS) (Dominant)</li><li>Polymerase Chain Reaction (PCR)</li><li>DNA Microarray</li><li>Cytogenetic Testing (FISH)</li></ul><p><strong>By Application</strong></p><ul><li>Oncology (High Growth)</li><li>Genetic Disease Diagnosis</li><li>Reproductive Health</li><li>Ancestry & DTC Wellness</li></ul><p><strong>By End-User</strong></p><ul><li>Hospitals & Clinics</li><li>Diagnostic Laboratories</li><li>Research & Academic Institutes</li></ul><p><strong>Buy this Premium Research Report: <a href="https://www.transparencymarketresearch.com/checkout.php?rep_id=10235&amp;ltype=S">https://www.transparencymarketresearch.com/checkout.php?rep_id=10235&amp;ltype=S</a> </strong></p><p><strong>About Transparency Market Research</strong></p><p><strong>Transparency Market Research</strong>, a global <a href="https://www.globenewswire.com/Tracker?data=MKyRdE0P94ioyU9f_0pp_wK0uV5-pktG40_qdemb39yORO5ij1UiDsjS3kZVPgI-OU0u348INknIe5Axs0iEQkizjjMb2WGH24rFxKRmG66df6VI3JqcmmcboAodjufF"><strong>market research company</strong></a> registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.</p><p>Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.</p><p><strong>Contact:</strong></p><p><strong>Abhishek Budholiya<br />Transparency Market Research Inc.<br /></strong>State Tower, 90 State Street, Suite 700,<br />Albany NY - 12207, United States<strong><br />Tel: </strong>+1-518-618-1030<br /><strong>USA – Canada Toll Free: </strong>866-552-3453<strong><br />Website: </strong><a href="https://www.transparencymarketresearch.com"><strong>https://www.transparencymarketresearch.com</strong></a><strong> <br />Sales Inquiries: sales@transparencymarketresearch.com<br />Media Inquiries: </strong><a href="mailto:media@transparencymarketresearch.com"><strong>media@transparencymarketresearch.com</strong></a></p>